Skip to main content

Table 2 Immunohistochemical staining of the vWF, VEGF, or VEGFR2 and clinicopathological characteristics in patients with gastric cancer

From: Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity

Variables

vWF-positive

VEGF-positive

VEGFR2-positive

 

≤125.75

>125.75

p-value

≤68.12

>68.12

p-value

≤114.56

>114.56

p-value

Sex

         

 Female

15

18

 

17

16

 

14

19

 

 Male

31

35

0.619

32

34

0.851

30

36

0.307

Age, years

         

 ≥57

23

30

 

25

28

 

29

24

 

 <57

21

25

0.256

24

22

0.736

22

24

0.674

Lymph node metastasis

         

 No

10

15

 

14

11

 

12

13

 

 Yes

32

42

0.059

35

39

0.692

40

34

0.716

TNM stage

         

 I + II

20

10

 

16

14

 

15

15

 

 III + IV

20

49

0.019*

20

49

0.016*

19

50

0.013*

Histological type

         

 Differentiated

13

17

 

18

12

 

16

14

 

 Undifferentiated

30

39

0.173

25

44

0.043*

23

46

0.023*

  1. *p < 0.05; statistical significant values indicated by bold font.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us